Ticker Details
OmniAb, Inc.
IPO Date:	September 30, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$217.17M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.09 | 2.64%
Avg Daily Range (30 D):	$0.04 | 2.44%
Avg Daily Range (90 D):	$0.04 | 2.32%

Institutional Daily Volume
Avg Daily Volume:	.53M
Avg Daily Volume (30 D):	.23M
Avg Daily Volume (90 D):	.3M

Trade Size
Avg Trade Size (Sh.):	117
Avg Trade Size (Sh.) (30 D):	105
Avg Trade Size (Sh.) (90 D):	114

Institutional Trades
Total Institutional Trades:	113
Avg Institutional Trade:	$1.55M
Avg Institutional Trade (30 D):	$.83M
Avg Institutional Trade (90 D):	$2.47M
Avg Institutional Trade Volume:	.53M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.61M
Avg Closing Trade (30 D):	$.83M
Avg Closing Trade (90 D):	$2.47M
Avg Closing Volume:	472.39K

News

Jun 30, 2025 @ 1:50 PM AI Is Quietly Reinventing Healthcare--And Real Dep... Source: Prnewswire

May 5, 2025 @ 4:59 PM VERAXA Biotech Enters Co-discovery Alliance with O... Source: N/A

Apr 30, 2024 @ 9:55 PM USANA Health Sciences (USNA) Q1 Earnings and Reven... Source: Zacks Equity Research

Mar 26, 2024 @ 12:40 PM Over $1M Bet On OmniAb? Check Out These 3 Stocks I... Source: Avi Kapoor

Mar 5, 2024 @ 10:35 PM Plus Therapeutics (PSTV) Reports Q4 Loss, Tops Rev... Source: Zacks Equity Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.57	$-.11	$-.57
Diluted EPS	$-.57	$-.11	$-.57
Revenue	$18.67M	$8.38M	$18.67M
Gross Profit
Net Income / Loss	$-64.78M	$-14.18M	$-64.78M
Operating Income / Loss	$-68.97M	$-15.77M	$-68.97M
Cost of Revenue
Net Cash Flow	$-2.07M	$-3.01M	$-2.07M
PE Ratio